Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
QuantumPharm, Inc. ( (HK:2228) ) has provided an announcement.
XtalPi Holdings Limited has announced a strategic move to place 264 million new shares under a general mandate, priced at HK$4.28 per share. This placement represents approximately 7.73% of its current issued share capital, aiming to raise gross proceeds of HK$1,130 million. This initiative, which does not require additional shareholder approval, is expected to provide significant capital to support the company’s operations and growth in the competitive pharmaceutical market.
More about QuantumPharm, Inc.
XtalPi Holdings Limited, formerly known as QuantumPharm Inc., operates in the pharmaceutical industry, focusing on innovative drug discovery and development. The company is incorporated in the Cayman Islands and is publicly traded with a stock code of 2228.
YTD Price Performance: -22.24%
Average Trading Volume: 83,824,502
Technical Sentiment Consensus Rating: Strong Buy
Learn more about 2228 stock on TipRanks’ Stock Analysis page.
